Parkinson's disease (PD) is a neurodegenerative condition caused by the loss of dopaminergic neurons in the substantia nigra that mani fests clinically in the form of characteristic motor defects 1 . Most cases of PD are sporadic and found in people above the age of 60, but roughly 10% of cases are hereditary forms with an earlier onset. Autosomalrecessive juvenile Parkinsonism (ARJP) is caused by mutations in around 15 PARK genes that have been annotated to date 2 . The Ser/Thr kinase PINK1 was one of the first PARK genes to be identified 3 . Mutation of pink1 in Drosophila caused PDlike symptoms, and linked PINK1 to the E3 ubiquitin ligase Parkin 4-8 . Detailed functional reconstruction has since linked PINK1 and Parkin to mitophagy, an important mitochondrial qualitycontrol process [9] [10] [11] . Mitochondrial damage and subsequent loss of mitochondrial membrane potential leads to the stabilization of PINK1 on the mito chondrial outer membrane (MOM) 12 and subsequent dimerization, autophosphorylation and activation of PINK1 [13] [14] [15] [16] . PINK1 activity leads to phosphorylation of ubiquitin on Ser65 (hereafter referred to as phosphoubiquitin) [17] [18] [19] [20] [21] , and to phosphorylation of the Ubl domain of Parkin on its structurally identical Ser65 residue 16, [21] [22] [23] [24] [25] . Together, phosphorylation and phosphoubiquitin binding lead to localized Parkin activation on mitochondria, where Parkin ubiquitinates MOM proteins 26 , triggering a feedforward mechanism 21 . Mitochondrial ubiquitination recruits mitophagy adaptors and initiates clearance of the damaged mitochondria 9, 10, 27, 28 . PINK1 is one of the most divergent human protein kinases 29 . It contains an Nterminal mitochondriatargeting and transmem brane segment, an unconserved region, a kinase domain with three insertions in the N lobe, and a conserved Cterminal region (CTR) of unknown function and structure (Fig. 1a, Extended Data Fig. 1 ). Although distinct from other kinases, PINK1 is highly conserved across species (Extended Data Fig. 1 ), which has led to the identification of insect PINK1 orthologues including that of the body louse (Pediculus humanus corporis), PhPINK1. PhPINK1 can be expressed in large quantities in Escherichia coli 30 .
Enabling structural studies of PINK1
PINK1 phosphorylates Ser65, which is protected in the ubiquitin fold, and is therefore an unlikely phosphorylation site. Building on previous work on phosphoubiquitin 20 (Extended Data Fig. 2) , we have recently shown that wildtype ubiquitin adopts an equilibrium between the 'common' ubiquitin conformation and a distinct second conforma tion, in which β5strand slippage retracts the C terminus and extends the Ser65containing loop by two residues 31 (Extended Data Fig. 2 ). This UbCR conformation is low in abundance, but can be stabilized by point mutations including T66V/L67N (hereafter referred to as UbTVLN 31 , Extended Data Fig. 2 ). Importantly, PhPINK1 binds to UbTVLN with higher affinity than it does to wildtype ubiquitin, and the interface encompasses the extended Ser65 loop 31 . Consequently, PINK1 has a preference for UbTVLN as a substrate in comparison to the common ubiquitin conformation 31 . In order to exploit this insight, we raised llama nanobodies (see Methods) against a chemically crosslinked PhPINK1-UbTVLN complex (Fig. 1b) . Nanobody 696 (Nb696) did not bind UbTVLN and interacted only weakly with PhPINK1 (Extended Data Fig. 3a ), but formed a gel filtrationstable, noncovalent trimeric complex when both were present (Extended Data Fig. 3a-c) . Also, neither UbTVLN nor Nb696 alone affected PhPINK1 stability, but Nb696 together with UbTVLN increased the melting temperature of PhPINK1 by around 7 °C (Extended Data Fig. 3d ).
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5 2 | N A T U R E | V O L 5 5 2 | 7 D E C E M B E R 2 0 1 7 (Extended Data Fig. 4b, c) . The nanobody binds UbTVLN and both lobes of the kinase domain (Fig. 1d, Extended Data Fig. 4d , e), which indicates how it could stabilize the complex. Most importantly, the structure reveals how PhPINK1 binds UbTVLN via the N lobe, in particular through insertion 3, and also via the kinase C lobe, where Ser65 of UbTVLN is in a phosphoaccepting position (Fig. 1d, e ). This suggests that this structure represents a precatalytic state of ubiquitin phosphorylation by PINK1.
Unique structural features of PINK1
PhPINK1 adopts the wellcharacterized bilobal kinase fold 33 (Figs 1e, 2a, Extended Data Fig. 5a ). Comparison with an active protein kinase structure such as that of phosphorylase kinase 34 (Protein Data Bank (PDB) accession number 2PHK, Extended Data Fig. 5a , b) reveals highly similar conformations of the catalytically important DFG ('DFGin' , Asp357, Phe358, Gly359) and HRD (His332, Arg333, Asp334) motifs 35, 36 , formation of an essential Glu-Lys contact in the ATPbinding site (Glu214-Lys193 in PhPINK1), and highly similar R and C spines 36 , confirming that PhPINK1 is in an active conformation (Extended Data Fig. 5c ).
The PhPINK1 structure highlights unique features of PINK1, such as the architecture of the CTR (Fig. 2a, b , Extended Data Fig. 1 ). Four additional helices (αJ-αM) pack tightly against the C lobe such that the last two helices (αL and αM) are enveloped by the CTR αJ and αK helices on one side, and the Clobe helices αE, αH and αI on the other side (Fig. 2a, b) , forming an extended hydrophobic core (Extended Data  Fig. 5d ). From this architecture it is clear how loss of the CTR would affect the activity and stability of PINK1 30, 37 . Exposed surface residues of the CTR do not show a high degree of evolutionary conservation (Extended Data Fig. 5e ), and it is unclear whether and how the CTR contributes to PINK1 function beyond stabilization.
The most striking differences between the PhPINK1-UbTVLN complex and other kinase structures are located in the kinase N lobe, which contains the three unique insertions, and also features an αB helix and an unusually short singleturn αC helix 36 that harbours Glu214 (Fig. 2c-e, Extended Data Fig. 5a, c) .
Insertion 1 (5 amino acids in PhPINK1, 34 amino acids in human (h)PINK1, Extended Data Fig. 1 ), which connects strands β2 and β3, is disordered (Fig. 2c) . Insertion 2 (19 amino acids in PhPINK1, 21 amino acids in hPINK1) connects the αC helix to the β4 strand, and forms a short βstrand (βi, parallel to β4) and an αi helix suspended above the αB-αC surface (Fig. 2d) . Insertion 3 (27 amino acids in PhPINK1 and hPINK1) is located between strands β4 and β5, and forms an ordered subdomain that lacks secondary structure, but binds ubiquitin (Figs 1e, 2a-e, 3). This element is the bestconserved insertion in PINK1 (Extended Data Fig. 1 ), underscoring its functional importance. Finally, the N lobe contains two conserved phosphorylated residues, Ser202 and Ser204 ( Fig. 2e ; Ser228 and Ser230 in hPINK1), which are discussed in 'Phosphorylation organizes Nlobe insertion' .
Ub-TVLN binding to PhPINK1
The PhPINK1-UbTVLN structure has provided an opportunity to characterize a transient kinase-substrate complex. PhPINK1 binds UbTVLN via a 751 Å 2 interface, and forms bipartite interactions with the N lobe and the activation segment in the C lobe (Fig. 3a) . The Nlobe part of the interface includes a pocket created by the Glyrich Cross-linking
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Low binding af nity loop (residues 164-174), insertion 3 and Phe196-Tyr198, which engulfs the ubiquitin hairpin residues Ala46-Gly47 (Fig. 3b , Extended Data Fig. 6a ). Tyr198 is a key residue that forms hydrophobic contacts with Ile44 and especially Val70 of ubiquitin, and a hydrogen bond with Gly47 ( Fig. 3b) . Several additional hydrogen bonds occur between insertion 3 and ubiquitin (Fig. 3b) . The Clobe part of the interface contains the PhPINK1 activation segment (residues 360-385), which contacts the extended Ser65 containing loop of UbTVLN (Fig. 3c) . The latter is held in place by polar contacts (linking ubiquitin Glu64 to PhPINK1 Asn383/Ala385, ubiquitin Val66 (Thr66 in wildtype ubiquitin) to PhPINK1 Asn383, and ubiquitin His68 to PhPINK1 Asp379). These contacts resemble those reported in kinase-substrate peptide complexes (Fig. 3c, d) , and place Ser65 close to a phosphoaccepting position. Flexibility in the Ser65 loop and kinase NtoClobe dynamics would enable catalysis in the presence of nucleotide.
We used mutational analysis to validate the ubiquitinbinding interface. A Y198E mutation in PhPINK1 did not affect autophospho rylation (Extended Data Fig. 7a ), but abolished phosphorylation of UbTVLN and ubiquitin (Fig. 3f) . Similarly, ubiquitin or UbTVLN with a G47E mutation was no longer phosphorylated (Fig. 3f) . ARJP mutations in insertion 3 (PhPINK1G281D or P268L, Fig. 3b , see below) reduced or abrogated kinase activity towards ubiquitin or UbTVLN, and in the case of G281D, also reduced autophosphoryla tion (Fig. 3f, Extended Data Fig. 7a ). PhPINK1D379A, which prevents contact with His68 on UbTVLN (Fig. 3c) , reduced phosphorylation of UbTVLN and ubiquitin, but not PhPINK1 autophosphorylation, while the ARJP mutation G382V abrogated kinase activity completely (Fig. 3f, Extended Data Fig. 7a ). This confirms the mode of ubiquitin binding, in line with previous biochemical findings 19,22,38 (Extended Data Fig. 6b) .
Strikingly, ubiquitin binding seems to be optimized towards the UbCR conformation. The β5strand shift in UbTVLN (Extended Data Fig. 2 ) juxtaposes Val70 and Tyr198 (Fig. 3b) , and allows His68 to contact the activation segment via Asp379 (Fig. 3c, Extended Data  Fig. 6c ). Superposition of wildtype ubiquitin onto UbTVLN suggests that substratepositioning interactions with the activation segment can be established only with an extended Ser65 loop (Fig. 3e, Extended  Data Fig. 6d ). This is consistent with NMR results showing that the Ser65 loop in wildtype ubiquitin does not partake in PhPINK1 con tacts 31 , and is also supported by hydrogen-deuterium exchange-mass spectrometry (HDXMS) data, which reveal that binding of UbTVLN involves the kinaseactivation segment, while wildtype ubiquitin does not contact the kinase C lobe (Extended Data Fig. 6e-f) . Nevertheless, wildtype ubiquitin binds to PhPINK1 and is phosphorylated, albeit at a roughly 50fold reduced rate 31 in comparison to UbTVLN, and NMR data indicate that the proteins interact via Ala46-Gly47, Ile44 and Arg42
31
, which is consistent with HDX-MS data (Extended Data  Fig. 6f ). It is possible that the common ubiquitin conformation binds the N lobe and transforms to the UbCR conformation while bound 31 . This would stabilize the interface and enable interaction with the acti vation segment and phosphorylation on Ser65.
Phosphorylation organizes N-lobe insertions
PINK1 activity is regulated by autophosphorylation 13, 15, 39 . Three phos phorylation sites, Thr305, Ser202 and Ser204, resisted λphosphatase treatment and were resolved in the crystal structure of active PhPINK1. Thr305 is not conserved (Extended Data Fig. 1) , and is in an exposed position on the C lobe (Extended Data Fig. 7b ). By contrast, Ser202 and Ser204 (Ser228 and Ser230 in hPINK1) are highly conserved (Extended Data Fig. 1 ), and autophosphorylation of hPINK1 on Ser228 is impor tant for kinase activity 13, 15 . The structure explains the important role of phosphoSer202 and phosphoSer204 in coordinating insertion 3 and insertion 2, respectively (Fig. 4a) . PhosphoSer204 provides an anchor point for insertion 2 to rest on the αB-αC helix. Similarly, insertion 3 residues Arg282 and Asn283 wrap around phosphoSer202, locking the end of insertion 3 in place (Fig. 4a) .
Hence, while UbTVLN does not contact phosphoSer202 directly, the structural effect of Ser202 phosphorylation on insertion 3 may affect ubiquitin binding. Consistent with this hypothesis, PhPINK1 S202A/S204A and PhPINK1R282A/N283A are unable to phospho rylate UbTVLN or ubiquitin (Fig. 4b) . Moreover, these mutants are less autophosphorylated, confirming severe kinase impairment 15 ( Fig. 4b, Extended Data Fig. 7a) . Indeed, the ARJP mutation G281D would also be predicted to disrupt insertion 3, and it has similar effects ( Fig. 3f) .
For more direct evidence of the importance of phosphorylation for ubiquitin binding, we performed pulldown and thermalstability Article reSeArcH assays with Nb696, which binds on the opposite surface of the kinase domain and does not contact the phosphorylation sites (Fig. 1d,  Extended Data Fig. 4d ). The PhPINK1-Nb696-UbTVLN trimeric complex is no longer formed when dephosphorylated PhPINK1 is used (Fig. 4c) . Rephosphorylation of PhPINK1 by adding Mg-ATP reinstates complex formation (Fig. 4c) . Also, PhPINK1S202A/S204A and PhPINK1R282A/N283A have reduced thermal stability (by about 3-4 °C), and are no longer stabilized by UbTVLN and Nb696 (Extended Data Fig. 7c) .
Together, this suggests that phosphorylation in the N lobe and, in particular, organization of insertion 3 by phosphoSer202, are crucial for kinase integrity and activity, as well as for binding of ubi quitin to the N lobe. The location of Ser202 and Ser204 would require autophospho rylation in trans, and would be an early event in PINK1 activation (see further discussion of autophosphorylation in Extended Data Fig. 7d ).
Molecular basis of AR-JP
The structure of PhPINK1-UbTVLN provides molecular explana tions for numerous mutations identified in individuals with ARJP. We collated mutation information from previous reviews 2, 9 and PDmutDB (http://www.molgen.vibua.be/PDMutDB/) and mapped the mutations onto the PhPINK1 structure ( Table 1 ). All reported homozygous hPINK1 mutations affect residues that are conserved in PhPINK1 (Supplementary Table 1 ). Several heterozygous mutations in hPINK1 also map to conserved residues in PhPINK1, and are likely to affect the structure or function of PINK1 (Fig. 5) . Some heterozygous mutations, however, affect resi dues that are not conserved in PhPINK1 (for example, in the extended hPINK1 insertion 1), or are in regions where the functional impact is unclear (Extended Data Fig. 8a , Supplementary Table 1) . PINK1 mutations can be categorized into mutations that affect the structure (Fig. 5a, Extended Data Fig. 8b-c ) and mutations that affect activity or substrate binding (Fig. 5b, Extended Data Fig. 8d ). The acti vation segment is a hot spot for structural mutations (Extended Data Fig. 8c ), highlighting the importance of its integrity. A wellstudied Nlobe mutation is T313M, which is a disputed phosphorylation site 15, 40 . The Thr313 equivalent in PhPINK1 is Ser285, which seems to be inaccessible for phosphorylation (Extended Data Fig. 8d ). However, substitution of Ser or Thr with the larger Met residue in the mutant would disrupt the N lobe and insertion 3, impeding both substrate phosphorylation and autophosphorylation 15, 40 . Mutations around the ATPbinding pocket (Fig. 5) , and mutation of the DFG and HRD motifs, and the αChelix Glu residue (hPINK1E240K) affect kinase activity (Fig. 5b, Supplementary Table 1 ). Finally, several mutations are located in the ubiquitinbinding interface (Fig. 5b) , including G309D (Gly281 in PhPINK1) and P296L (Pro268 in PhPINK1) in insertion 3 (see Fig. 3b ), and G409V in the activation loop (Gly382 in PhPINK1) (Fig. 3c ). As shown above, these ARJPcausing mutations reduce or abolish ubiquitin phosphorylation when introduced into PhPINK1 (Fig. 3f ).
Discussion
The structure of PhPINK1 bound to ubiquitin provides molecular explanations for earlyonset Parkinson's disease in the cohort of patients with mutations in the PINK1 gene, and provides detailed insight into how ubiquitin, a wellfolded protein and unlikely kinase target, is phosphorylated on its protected Ser65. We show how PhPINK1 inter acts with the recently identified UbCR conformation of ubiquitin 31 through its kinase N lobe, partly via its unique insertion 3. Crucially, the UbCR conformation, but not the common ubiquitin conformation, is able to form substratelike interactions with the activation segment of PhPINK1. The structural and biochemical evidence provided here and elsewhere 31 suggest that the lowabundance UbCR conformation of ubiquitin is the PINK1 kinase substrate, underlining its physiological importance. Moreover, rather than 'selecting' or 'inducing' the UbCR conformation, PhPINK1 may bind to the common conformer of the substrate and allow it to transition to the phosphorylatable UbCR conformation in situ. Similar mechanisms of local transitions upon substrate binding could exist for the Parkin Ubl domain (for which a UbCRlike conformer has not been reported, see Extended Data Fig. 6 ), or indeed for other kinases that phosphorylate protected res idues in folded substrates; this includes PKRmediated phosphoryla tion of eIF2α, which appears to be conceptually similar 41 . However, there are few complex structures of kinases bound to their protein substrates, because the mechanism of phosphorylation enables high turnover and does not maintain stable precatalytic states. We trapped such a state by exploiting a nanobody that stabilizes the PhPINK1-UbTVLN complex. The resulting structure explains a large body of biochemical data, and will help to reconcile controversies in the litera ture. For example, the structure explains the architecture of the PINK1 CTR and the unusual features of the N lobe, with its insertions, regula tory phosphorylation sites, and variations of common kinase elements. An apo structure of Triboleum castaneum PINK1 lacking insertion 3, and hence unable to bind and phosphorylate ubiquitin, was reported recently 42 . Together, the structures finally provide an explanation for why PINK1 is one of the most divergent protein kinases in the human kinome 29 . They also represent a first key step towards identifying and optimizing activators of PINK1mediated mitophagy events that may benefit patients with Parkinson's disease 43 . Interesting new pharmaco logical strategies could emerge from ubiquitin conformational modu lators that may affect ubiquitin phosphorylation levels.
Mutations affecting protein fold
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, and the Nb696 construct was cloned into a pMESy4 vector. Sitedirected mutagenesis and con struct optimization were carried out using the QuikChange and InFusion protocols using Phusion polymerase (NEB). Protein purification. PhPINK1 constructs were expressed in Rosetta 2 (DE3) pLacI cells in 2 × TY medium. Protein expression was induced at OD 600 of 0.6-0.8 with 200 μM isopropyl βd1thiogalactopyranoside (IPTG) and cells were collected after 12 h incubation at 20 °C. GSTtagged PhPINK1 constructs (residues 115-575) were purified as described previously 20 . The GST tag was removed using PreScission protease. SUMOtagged PhPINK1 constructs (residues 115-575) were purified using HisPur Cobalt Resin (Thermo Fisher Scientific). The His-SUMO tag was cleaved using SENP1 during dialysis in cleavage buffer (25 mM Tris (pH 8.5), 200 mM NaCl, 2 mM βmercaptoethanol) overnight at 4 °C. PhPINK1 constructs (residues 115-575) were purified by size exclusion chroma tography (SEC; Superdex 75 or Superdex 200, GE Life Sciences) in buffer A (25 mM Tris (pH 8.5), 150 mM NaCl, 5% glycerol, 10 mM DTT). Ubiquitin constructs were purified as described previously 20 by SEC (Superdex 75) in buffer B (25 mM Tris (pH 7.4) 150 mM NaCl) as the final step. PhPINK1 was dephosphorylated using a 1:5 ratio of λphosphatase in buffer A supplemented with 0.5 mM MnCl 2 . λPhosphatase was removed by SEC in buffer A. For purification of PhPINK1 (residues 143-575) for crystallography see 'Protein preparation for crystallization' . PhPINK1-Ub-TVLN crosslinking for nanobody selection. Cterminally His tagged UbTVLN (130 μl, 1 mM) was added to 1.8 ml of 24 μM PhPINK1 in 25 mM Tris (pH 8.5), 200 mM NaCl, 2 mM βmercaptoethanol. The reaction was started by adding 100 μl of 2 mg ml −1 crosslinker mix from the K200 stabilization kit (CovalX). The reaction was incubated for 1 h at 22 °C. The formed complex was purified via the Cterminal His tag of UbTVLN using HisPur Cobalt Resin (Thermo Fisher Scientific) and eluted with buffer A supplemented with 250 mM imidazole. The complex was purified further by SEC (Superdex 200) in buffer A. Fractions containing the complex were pooled, concentrated to 1.1 mg ml −1 , vitrified in liquid nitrogen, and stored at −80 °C for immunisation. Generation and selection of PhPINK1-Ub-TVLN-specific nanobodies by phage display. A llama was immunized with a total of 820 μg of crosslinked PhPINK1-UbTVLN over a period of six weeks using previously established protocols 45 . Blood from the immunized llama was treated with anticoagulant, and lympho cytes were used to prepare cDNA that served as a template to amplify the open reading frames coding for the variable domains of the heavychainonly antibodies. The PCR fragments were ligated into the pMESy4 phagedisplay vector and trans formed into E. coli TG1 cells. A nanobody library of 10 9 transformants was obtained with an insert rate of 100% as determined by PCR. After superinfection with helper phage, the nanobody repertoire of this library was expressed on the tip of the phage and a selection of phage particles expressing nanobodies that specifically bind to target protein was performed 45 . Two different selection methods were used to select for phage binding specifically to PhPINK1-UbTVLN. First, the crosslinked material was solidphase coated on MaxiSorp ELISA plates, and phage displaying nanobodies were added directly to the crosslinked material. Second, phage were preincubated with 1 μM free PhPINK1 before being added to the crosslinked complex. Selections were done in 25 mM Tris (pH 8.5), 150 mM NaCl, 1 mM DTT.
After selection, phage were eluted by incubating the complexcoated wells with 100 μl of trypsin (250 μg ml Nb696 was expressed in the periplasm of WK6Su − E. coli 45 grown in 2 × TY medium. Protein expression was induced at an OD 600 of 0.6-0.8 with 200 μM IPTG and cells were collected after 12 h at 30 °C. The cell pellet was resuspended in TES buffer (200 mM Tris, 0.5 mM EDTA, 0.5 M sucrose (pH 8.0)) for 1 h at 4 °C and centrifuged at 15,000g at 4 °C. The supernatant containing nanobodies was purified further using HisPur Cobalt Resin without removing the His tag. Finally, Nb696 was purified by SEC (Superdex 75) in buffer B. Protein preparation for crystallization. The PhPINK1 crystallization construct (residues 143-575) was expressed as a SUMOfusion construct as described above and purified using a HiTrap nickel column (GE Life Sciences). The SUMO tag was removed during dialysis in cleavage buffer (25 mM Tris (pH 7.2), 150 mM NaCl, 5% glycerol, 2 mM βmercaptoethanol) overnight at 4 °C and captured on the nickel column. The flowthrough was purified further using a Resource Q column (GE Life Sciences). Pure PhPINK1containing fractions were pooled and mixed with Nb696 and UbTVLN in a 1:2:2 ratio. The complex was purified further by SEC (Superdex 200) in (25 mM HEPES (pH 7.0), 300 mM NaCl, 5% glycerol, 10 mM DTT). Fractions containing complexes were pooled, concentrated and dephosphorylated using a 1:5 ratio of λphosphatase in 25 mM HEPES (pH 7.0), 300 mM NaCl, 5% glycerol, 0.5 mM MnCl 2 10 mM DTT for 1 h at 22 °C. The λphosphatase was removed and the complex was purified further by SEC (Superdex 200) in crystallization buffer (25 mM HEPES (pH 7.0), 300 mM NaCl, 5% glycerol, 10 mM DTT) and concen trated to 7-9 mg ml −1
. The PhPINK1-Nb696-UbTVLN complex was crystallized at 7 mg ml −1 by sittingdrop vapour diffusion against 1.3 M ammonium tartrate dibasic, 0.1 M bisTris propane (pH 7.0) from a 1:1 protein to mother liquor ratio, in 100 nl drops at 22 °C. Crystals were optimized using streak seeding at 8.9 mg ml −1 complex concentration in 1.4 M ammonium tartrate, 0.1 M bisTris propane (pH 6.3) at 22 °C. Crystals were collected after 3-4 days, cryoprotected in 35% glycerol, 1.0 M ammonium citrate, 0.1 M bisTris propane (pH 7.0), and vitrified in liquid nitrogen. Data collection, phasing and refinement. Diffraction data was collected at the Diamond Light Source, beam line I04 (0.98 Å, 100 K), and processed using Xia2 46 (v.0.5.270ge1c2909edials1.5). The crystal structure was determined by molecular replacement in Phaser 47 (as implemented in Phenix v.1.11.12575) using a polya lanine model of CDPK1 from Plasmodium bergheii (PDB: 3Q5I) for PhPINK1, and a polyalanine model of the nanobody of the LacY-nanobody com plex (PDB: 5GXB, unpublished) for Nb696, and the phosphoUbTVLN structure (PDB: 5OXH 31 ) for UbTVLN. The original solution was rebuilt at 3.1 Å from the models, in multiple rounds of model building in Coot 49 (v.0.7.
2) and refinement in PHENIX 50 (v.1.11.12575) and Refmac (CCP4 v.6.4.0). Final Ramachandran statistics: 96.7% favoured, 3.1% allowed, and 0.2% outliers. Structural figures were generated using PyMol (v.1.8.6.2 enhanced for Mac OS X, http://www.pymol.org). The following residues lacked electron density and were not modelled: PhPINK1 143-146 (N terminus), 181-186 (insertion 1), 227-228 (insertion 2), 514-538 (CTR), and 575 (C terminus); Nb696 127-134 (C terminus); UbTVLN 74-76 (C terminus).
Data collection and refinement statistics can be found in Extended Data Table 1 . Phos-tag assays. Ubiquitin constructs were phosphorylated by incubating 15 μM of substrate with PhPINK1 (residues 115-575, concentrations as indicated) in 25 mM Tris (pH 7.4), 150 mM NaCl, 10 mM MgCl 2 , 10 mM ATP, 1 mM DTT at 22 °C. Reactions were quenched at the indicated time points in EDTAfree lithium dodecyl sulfate (LDS) loading buffer. Samples were separated by Mn 2+ Phostag SDS-PAGE, using 17.5% (w/v) acrylamide gels supplemented with 50 μM Phos tag AAL solution (Wako Chemicals) and 50 μM MnCl 2 using an EDTAfree Tris glycine running buffer. Gels were stained with Instant Blue SafeStain (Expedeon). Pull-down assays. Pulldown assays were performed by mixing 10 μM Nb696 with 10 μM PhPINK1 (residues 115-575) and 20 μM UbTVLN in pulldown buffer (25 mM Tris (pH 8.5), 150 mM NaCl, 1 mM βmercaptoethanol) at 22 °C. Dephosphorylated PhPINK1 was preincubated with 10 mM ATPMgCl 2 for 1 h at 22 °C prior to the pulldown experiment. The complex was captured via the His tagged Nb696 using HisPur NiNTA Resin (Thermo Fisher Scientific) on Proteus Clarification mini spin columns (Generon). Unbound protein was removed by several centrifugation rounds at 14,000g in pulldown buffer at 22 °C. Bound pro teins were eluted with pulldown buffer supplemented with 250 mM imidazole and LDS loading buffer was added. Loading and bait samples were diluted 1:5 with LDS loading buffer and samples were resolved on 4-12% SDS-PAGE gradient gels (NuPage) and stained with Instant Blue SafeStain (Expedeon). Thermal denaturation assays. Assays were performed by mixing 4 μM PhPINK1 (residues 115-575) or indicated PhPINK1 mutants with 8 μM Nb696 and/or 20 μM UbTVLN in 25 mM Tris (pH 8.5), 150 mM NaCl. SYPRO Orange (Thermo Fisher Scientific) was added to the samples and melting curves were recorded using a RotorGene 6000 (Corbett Research) and analysed with the RotorGene 6000 Series Software (v.1.7, build 75, Corbett Research). Representative melting curves and the derived melting temperatures were plotted with GraphPad Prism (v.7.0b). Nine technical replicates were measured per sample. Mass spectrometric analysis of phosphorylation states. Intact proteins were analysed by LC-MS. In brief, a modified NanoAcquity (Waters) delivered a flow of approximately 50 μl min −1 . Proteins were trapped on a C8 UPLC BEH 1.7 μm, 2.1 × 5 mm precolumn (Waters) before separation on a C8 BEH 1.7 μm, 1.0 × 100 mm UPLC column. Proteins were eluted with a 60 min gradient of acetonitrile (2-80% (v/v)). The outlet of the analytical column outlet interfaced directly with a hybrid quadrupole timeofflight (QTOF) mass spectrometer (Xevo G2, Waters) via an electrospray ionisation (ESI) source. Data were acquired over a m/z range of 350-2,000, in positive ion mode with lock mass calibration using Article reSeArcH labelling reaction was quenched by the addition of chilled 2.4% (v/v) formic acid in 2 M guanidinium hydrochloride and immediately frozen in liquid nitrogen. Samples were stored at −80 °C before analysis.
The quenched protein samples were rapidly thawed and subjected to proteolytic cleavage by pepsin followed by reversedphase highperformance liquid chroma tography (HPLC) separation. In brief, the protein was passed through an Enzymate BEH immobilized pepsin column (2.1 × 30 mm, 5 μm, Waters) at 200 μl min −1 for 2 min, and the peptic peptides were trapped and desalted on a 2.1 × 5 mm C18 trap column (Acquity BEH C18 Vanguard precolumn, 1.7 μm, Waters). Trapped peptides were subsequently eluted over 11 min using a 3-43% (v/v) gradient of acetonitrile in 0.1% (v/v) formic acid at 40 μl min −1
. Peptides were separated on a reversephase column (Acquity UPLC BEH C18 column 1.7 μm, 100 mm × 1 mm, Waters) and detected on a SYNAPT G2Si HDMS mass spectrometer (Waters) over am m/z of 300-2,000, with the standard ESI source with lock mass calibration using [Glu1]fibrino peptide B (50 fmol μl −1
). The mass spectrometer was operated at a source temperature of 80 °C and a spray voltage of 2.6 kV. Spectra were collected in positiveion mode. Data were acquired using MassLynx (v.4.1 SCN924, Waters).
Peptides were identified by MS E (ref. 51) using an identical gradient of increas ing acetonitrile in 0.1% (v/v) formic acid over 11 min. The resulting MS E data were analysed using Protein Lynx Global Server software (v.3.0.1, Waters) with an MS tolerance of 5 p.p.m.
Mass analysis of the peptide centroids was performed using DynamX software (v.3.0, Waters). Only peptides with a score larger than 6.4 were considered. The first round of analysis and identification was performed automatically by the DynamX software; however, all peptides (deuterated and nondeuterated) were manually verified at every time point for the correct charge state, presence of overlapping peptides, and correct retention time. Deuterium incorporation was not corrected for backexchange and represents relative, rather than absolute changes in deute rium levels. Changes in hydrogen-deuterium amide exchange in any peptide may be due to a single amide or a number of amides within that peptide. Three data sets were generated in total: PhPINK1 alone, PhPINK1Nb696UbTVLN, and PhPINK1Nb696Ub WT. The peptide masses of PhPINK1 alone were subtracted from the respective peptide masses of PhPINK1Nb696UbTVLN or PhPINK1 Nb696Ub WT, respectively. The mass differences were plotted with the middle amino acid of each peptide with GraphPad Prism (v.7.0b). Data availability. Coordinates and structure factors have been deposited with the Protein Data Bank under accession number 6EQI. Uncropped versions of all gels are displayed in Supplementary Fig. 1 . All data and reagents are available upon request from the corresponding author.
Article reSeArcH PINK1 orthologues from different species were aligned using MUSCLE 52 . Secondary structure elements are shown and coloured as in Fig. 1 . The β6 and the β9 sheets often observed in kinases form highly analogous interactions, but are not annotated as βstrand secondary structure elements in PhPINK1. The amino acid sequences of regions with no structural information are coloured grey. Catalytic residues and phosphorylation sites are highlighted in red and orange, respectively. The positions of insertions 1, 2, and 3 are highlighted in yellow. Stars indicate residues that are mutated in patients with ARJP, and are coloured according to their structural roles (see Fig. 5 54 , we found that a very small ('invisible') population of unphosphorylated wildtype ubiquitin adopts a UbCR conformation 31 . c, We were able to stabilize the UbCR conformation in unphosphorylated ubiquitin by mutating Thr66 to Val, and Leu67 to Asn. The resulting UbTVLN mutant adopts the UbCR conformation in the unphosphorylated state, binds PhPINK1 with higher affinity via its exposed Ser65containing loop, and is consequently an approximately 50fold more efficient substrate for PhPINK1 31 . Phosphorylated UbTVLN also adopts the UbCR conformation 31 . d, Important structural differences between the common conformation of wildtype ubiquitin and the Ub-CR conformation of Ub-TVLN. The latter extends the Ser65 loop, which becomes flexible and solventexposed, while the C terminus is shortened. Moreover, the important Ile44 hydrophobic patch becomes disjointed as Val70 and His68 are shifted on the ubiquitin surface in the UbCR conformation. The new conformation therefore has several unique features that can be exploited by binding partners. Indeed, the properties of UbCR as a superior substrate and the knowledge that wildtype ubiquitin exists in the UbCR conformation are consistent with the idea that PINK1 utilizes this conformation during phosphorylation 31 .
Article reSeArcH (residues 143-575) , which also formed a stable trimeric complex with Nb696 and UbTVLN. Gel filtration runs with identical compositions were performed eleven times, and a representative experiment is shown. f, Coomassiestained SDS-PAGE of protein containing fractions of the representative experiment shown in e. Fractions from three gel filtration runs have been analysed with identical results. g, PhPINK1 (residues 143-575) was expressed in E. coli and is autophosphorylated in the PhPINK1Nb696UbTVLN complex at six to nine sites (top left). Dephosphorylation of the complex with λphosphatase (λPP) results in a species that is homogeneously phosphorylated at three sites on PhPINK1 (top right). λPhosphatase treatment does not affect intact mass of either Nb696 or UbTVLN in MgATPfree conditions (bottom). A second PhPINK1 species with lower abundance, which is presumed to be acetylated, was also detected and has the same phosphorylation pattern as the more abundant species (*, top left). The dephosphorylated complex was used for crystallization. All experiments were performed as technical duplicates. 
Article reSeArcH

Extended Data Figure 6 | Ub-TVLN and Ser65-loop binding to PhPINK1. a, View focusing on the Ala46-Gly47 hairpin of UbTVLN, which occupies a pocket on the PhPINK1 N lobe between the Glyrich loop, Tyr198, and insertion 3. PhPINK1 is shown under a surface to highlight shape complementarity. b, UbTVLN bound to PhPINK1, showing the position of Lys residues. Several Lys residues display disordered side chains and were modelled in their most favourable rotamers. Lys6 and Lys48 are close to the interface with PhPINK1, which may prevent binding to ubiquitin moieties that are ubiquitinated at these sites (that is, internal ubiquitin molecules in a ubiquitin polymer). This is consistent with recent evidence that PhPINK1 phosphorylates Lys6 and Lys48 chains with a preference for the distal ubiquitin 38 . c, d, Direct comparison of UbTVLN and wildtype ubiquitin binding to PhPINK1. c, In UbTVLN, the UbCR conformation enables optimized contacts with Val70, and allows His68 to contact the activation segment. d, In wildtype ubiquitin, the Gly47 hairpin is identical to the one in UbTVLN, and can form contacts with the N lobe, but Tyr198 in PhPINK1 is juxtaposed with the larger and more hydrophilic His68, and Val70 is not involved in the interaction. Moreover, the Ser65 loop is unable to contact the activation segment. The difference in the ability of the Ser65 loops to partake in the interaction with PhPINK1 was seen in NMR studies 31 . e, f, HDXMS studies of PhPINK1 bound to Nb696 and UbTVLN or wildtype ubiquitin (see Methods). Experiments were performed as technical triplicates. Differences in PhPINK1 deuterium uptake upon complex formation with either Nb696+UbTVLN or Nb696+Ub WT are shown for 3 s, 30 s, and 300 s timepoints. Mass differences are plotted on the middle amino acids of the respective peptides. The data revealed identical binding sites for ubiquitin and UbTVLN in the N lobe of PhPINK1 (pink, yellow boxes), consistent with the complex structure. Importantly, UbTVLN also binds to the Clobe activation segment (orange box), whereas this interaction is not seen with wildtype ubiquitin. It is also apparent that UbTVLN protects PhPINK1binding sites more efficiently, suggesting that the UbTVLNcontaining complex is more stable (compare 300 s datasets, red). g, h, Structure of the Ubl domain of Parkin resembles wildtype ubiquitin (green, Parkin UblR33Q crystal structure, PDB: 3B1L, unpublished). g, Conservation of residues at the PhPINK1 interface (including Ala46-Gly47) would suggest a similar PhPINK1binding mode to wildtype ubiquitin. A UbCR conformer for the Parkin Ubl has, however, not been reported, and a superposition (h) shows that, like wildtype ubiquitin, the Parkin Ubl domain would be unlikely to be able to bind the activation segment. NMR analysis, however, suggests that the Parkin Ubl Ser65 loop displays higher structural flexibility 62 .
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Data exclusions
Describe any data exclusions. Data exclusion in crystallographic datasets (outlier reflection rejection) was carried out automatically as implemented in the Xia2 pipeline using pre-established criteria. No biochemical data was excluded.
Replication
Describe whether the experimental findings were reliably reproduced.
All attempts at replications were successful.
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
The quantitative biophysical experiments did not require the use of randomization.
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
The quantitative biophysical experiments did not require the use of blinding.
Note: all studies involving animals and/or human research participants must disclose whether blinding and randomization were used.
Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
